Delivery Order SPE2DB24D3013-SPE2DB25FFJUY

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $108,308.71 firm fixed-price delivery order covers the procurement of 4,534,839 units of procainamide, a medication used to treat heart rhythm disorders. The contract has an ultimate completion date of August 4, 2016 and was awarded on July 8, 2016. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,377.45 firm-fixed-price delivery order is for the supply of procainamide, a medication used to treat certain heart rhythm disorders. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $92,399.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,774.50 Firm Fixed Price Delivery Order contract is for the supply of 4,566,285,714 units of 10mL Procainamide, a medication used for the treatment of certain heart rhythm disorders. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,106.04 Firm Fixed Price Delivery Order covers the supply of 4561286235 - Procainamide 10ML 25S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a...
This is a federal contract award valued at $6,292.20 made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Procainamide 1 gram/10 ml vials, a medication used for cardiac conditions. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
This federal contract award is for the delivery of 4,566,332,629 units of the pharmaceutical product Procainamide 10ML 25S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $81,269.55 and is a firm-fixed price delivery order. It does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Procainamide 1 gram/10 ml vials. The $1,917.52 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of procainamide 1,000 mg/10 ml vials. The contract has a ceiling value of $3,068.29 and a completion date of November 21, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, with a ceiling value of $2,754.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565521177 - Procainamide 1 Gram/10 ML Vial 10ML, a critical medical supply. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFJUY
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,903.25, is a delivery order for the supply of procainamide, a medication used to treat certain heart rhythm disorders.

The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:12 AM